Learn More
Medchemexpress LLC EGFR-IN-69 | 2433837-65-9 | C31H37Cl2N7O3S | 5 MG

Supplier: Medchemexpress LLC HY1506105MG
EGFR-IN-69 (compound 17g) is a potent EGFR inhibitor used in non-small-cell-lung-cancer (NSCLC) research. It demonstrates strong inhibitory activity against multiple EGFR mutations, including EGFRL858R/T790M/C797S (IC50 4.3 nM), EGFRL858R/T790M (IC50 6.6 nM), and EGFR19del/T790M/C797S (IC50 25.6 nM). The compound also shows antiproliferative and cytotoxic effects on BaF3 cell lines.
- Potent EGFR inhibitor
- Inhibits EGFR L858R/T790M/C797S, L858R/T790M, and del19/T790M/C797S mutations
- Used in NSCLC research
- Antiproliferative and cytotoxic activity against BaF3 cell lines
- Light yellow to yellow solid
- 99.58% purity
- For research use only
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.